Skip to content
DefDex

Federal award

KEDRION BIOPHARMA INC

W81K0213P0121

Contract

Obligated and Ceiling

Obligated (net)
$154,256.59
Ceiling (potential value, not spending)
$154,256.59
Current value
$154,256.59
Gross positive obligations
$178,296.96

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
KEDRION BIOPHARMA INC · UN3DCKKLHSE7
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
KEDRION BIOPHARMA INC. · V2MKJBNWW7C3
Awarding agency
Department of War · sub-agency 2100 · office W81K02
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
6505 · DRUGS AND BIOLOGICALS
Industry (NAICS)
621111 · OFFICES OF PHYSICIANS (EXCEPT MENTAL HEALTH SPECIALISTS)
PIID
W81K0213P0121
Award type code
B
Actions
14 · Sep 27, 2013 to Sep 30, 2019
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History14

Award actions
DateFYModAction typeObligationCompany in company totals
Sep 30, 2019FY2019P00013K−$19,873.73
—
Oct 26, 2017FY2018P00012C$33,545.52
—
Sep 1, 2017FY2017P00011G$0.00
—
Aug 31, 2017FY2017P00010M$0.00
—
Oct 18, 2016FY2017P00009C$33,062.88
—
Aug 29, 2016FY2016P00008G$0.00
—
Apr 18, 2016FY2016P00007M−$4,166.64
—
Oct 21, 2015FY2016P00006C$37,229.52
—
Jun 10, 2015FY2015P00005G$0.00
—
Oct 16, 2014FY2015P00004C$37,229.52
—
Jun 23, 2014FY2014P00003G$0.00
—
Nov 19, 2013FY2014P00002C$37,229.52
—
Oct 17, 2013FY2014P00001M$0.00
—
Sep 27, 2013FY20130—$0.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.